MediWound

MediWound is a fully integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutics based on its patented proteolytic enzyme technology that addresses unmet needs in the fields of severe burns, chronic, and other hard-to-heal wounds. MediWound was founded in 2001 and is based in Israel.